The Division of Pediatric Cardiology is home to some of the country's best research aimed at understanding the molecular etiology of cardiac malformations and in the regulation of pulmonary vascular development. Other research interests include the molecular basis and genetics of sudden infant death syndrome, regenerative medicine/stem cell differentiation and tissue engineering, personalized medicine with particular emphasis on antiarrhythmic medications, and beta-blocker therapy versus angiotensin-2 receptor blocker therapy in individuals with Marfan syndrome.
The three-year pediatric cardiology fellowship program at Vanderbilt challenges trainees through intensive clinical experience and opportunities for investigative work in a number of clinical and basic research fields. The training program at Vanderbilt is approved by the American Council for Graduate Medical Education (ACGME).
Learn more about our academic programs in pediatric cardiology.
Learn about our Pediatric Heart Institute.